相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp
Emilie Palisaitis et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes
Lalantha Leelarathna et al.
DIABETES CARE (2020)
Randomized Controlled Trial of Mobile Closed-Loop Control
Boris Kovatchev et al.
DIABETES CARE (2020)
A qualitative study exploring the expectations of people living with type 1 diabetes regarding prospective use of a hybrid closed-loop system
A. Quintal et al.
DIABETIC MEDICINE (2020)
Limits of Correlation Coefficient Analysis in Determining the Minimal Duration of CGM Data Needed to Estimate Time Below Range
Nunzio Camerlingo et al.
DIABETES (2020)
Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial
Boris P. Kovatchev et al.
LANCET DIGITAL HEALTH (2020)
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
S. A. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial
Pierre-Yves Benhamou et al.
LANCET DIGITAL HEALTH (2019)
Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors
Jessica R. Castle et al.
DIABETES CARE (2018)
Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System
Laurel H. Messer et al.
DIABETES CARE (2018)
Technology in the management of type 1 diabetes mellitus - current status and future prospects
Martin Tauschmann et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
Martin Tauschmann et al.
LANCET (2018)
Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study
Lia Bally et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia
Eyal Dassau et al.
DIABETES CARE (2017)
Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial
Ahmad Haidar et al.
DIABETES OBESITY & METABOLISM (2017)
Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial
V. Gingras et al.
DIABETES & METABOLISM (2016)
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
David M. Maahs et al.
DIABETES CARE (2016)
Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy
P. G. Jacobs et al.
DIABETES OBESITY & METABOLISM (2016)
A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study
Veronique Gingras et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2016)
The Artificial Pancreas HOW CLOSED-LOOP CONTROL IS REVOLUTIONIZING DIABETES
Ahmad Haidar
IEEE CONTROL SYSTEMS MAGAZINE (2016)
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
Richard M. Bergenstal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Current State of Type 1 Diabetes Treatment in the US: Updated Data From the T1D Exchange Clinic Registry
Kellee M. Miller et al.
DIABETES CARE (2015)
Home Use of an Artificial Beta Cell in Type 1 Diabetes
H. Thabit et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial
Ahmad Haidar et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial
Ahmad Haidar et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
DM Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes
PE Cryer
DIABETOLOGIA (2002)
分享论文
